Form 4: Clover Health Executive's Stock Withholding for Taxes

Clover Health's General Counsel, Karen Soares, had 6,403 shares withheld to cover tax obligations upon the vesting of restricted stock units.

Summary

• Karen Soares, General Counsel & Secretary of Clover Health Investments, Corp., reported a transaction involving Class A Common Stock.
• 6,403 shares of Class A Common Stock were automatically withheld to cover tax obligations.
• This withholding occurred upon the vesting of restricted stock units (RSUs) on September 15, 2025.
• The vested amount represents 6.25% of the original RSUs granted to Ms. Soares on September 15, 2022.
• The shares were valued at $3.14 per share for the purpose of this withholding.
• Following this transaction, Ms. Soares beneficially owns 1,463,084 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation and tax withholding, which is a neutral event for the company's operational or financial performance.

Positives

• The transaction reflects the continued vesting of executive equity compensation, indicating ongoing tenure of a key executive.
• It is a routine, non-discretionary event related to compensation, not a sale initiated by the executive for personal liquidity.

Future Outlook

Remaining restricted stock units are scheduled to vest quarterly in equal installments of 6.25% until the final vesting date of September 15, 2026, contingent on Karen Soares' continued service to the company.

Management Comments

• The transaction represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting of time-based restricted stock units.

Industry Context

This type of transaction, involving the withholding of shares for tax purposes upon RSU vesting, is a standard practice in executive compensation across various industries. It does not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine compensation-related tax withholding event.
• Indicates the continued tenure and equity participation of a key executive, Karen Soares.

Next Steps

• Remaining restricted stock units are scheduled to vest quarterly in equal installments of 6.25% until September 15, 2026, subject to continued service of the Reporting Person.

Key Dates

Recommendation

The Form 4 filing details a routine, non-discretionary transaction where shares were withheld to cover tax obligations upon the vesting of restricted stock units for a key executive. This is a standard compensation event and does not provide new information that would alter the fundamental investment thesis for Clover Health. Therefore, a 'hold' recommendation is appropriate as there are no significant positive or negative catalysts presented in this filing.

Keywords

Clover Health, CLOV, Form 4, Insider Transaction, Stock Withholding, RSU Vesting, Executive Compensation, Karen Soares